🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

25 mcg (125% DV)
✅ 1.7× RDA — within safe limits 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.025mg UL 0.1mg
180 mcg (150% DV)
✅ 1.5× RDA — within safe limits 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.18mg

Other Ingredients

Glycerol Monostearate Hypromellose Microcrystalline Cellulose Silicon Dioxide Magnesium Stearate Food Starch, Modified Maltodextrin Sucrose Medium Chain Triglyceride Ascorbyl Palmitate Rosemary Extract Sodium Ascorbate DL-Alpha-Tocopherol

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Adult Use: Take 1 capsule daily with food, or as recommended by a nutritionally informed physician.

⚠️ Warnings & Precautions

Warning: This product contains vitamin K. Consult a physician before use if taking blood thinners.

🧪 Formulation Notes

Specially formulated with MenaQ7, the superior form of vitamin K, this daily supplement helps support your vessel walls and arteries. This thoughtful dosage of MenaQ7, when paired with vitamin D3, helps inhibit soft tissue calcification and promotes arterial flexibility. Plus, vitamin D3 (cholecalciferol) is a natural way to maintain healthy heart and cardiac function. Naturally fermented using chickpeas, MenaQ7 is produced using strict production standards to ensure optimum bioavailability.

Supports Arterial flexibility and health Calcium metabolism for maintaining healthy bones Soft tissue elasticity through effective vitamin K2 distribution

Non-GMO Gluten free Soy free

Vegetarian

Vitamin K2 as MK-7

Supports artery, soft tissue, and bone health

Additional Information

Stay young at heart.

Store in a cool dry place.

Product Details

UPC / SKU 7 53950 00404 7
DSLD Entry Date 2024-06-20
Product Type Vitamin
Form Capsule
DSLD ID 302697
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →